The previous experience of the United Kingdom Atomic Energy Authority with an aqueous influenza vaccine (Meichen, Rogan, and Howell, 1962) suggested that routine annual inoculation was not justified in a large industrial population. Among others who have reached a similar conclusion, Richardson and Kilpatrick (1964) found that their three-year immunization programme had so far produced no definite benefit. Nevertheless, the introduction of polyvalent oil-adjuvant vaccines to this country, with the theoretical advantage of a much smaller dose and the possibility of a longer period of protection, led to the decision to undertake a further large-scale trial in the Authority. Salk, Bailey, and Laurent (1952) and Salk, Contakos, Laurent, Sorensen, Rapalski, Simmons, and Sandberg (1953) concluded that emulsification in light mineral oil of low viscosity greatly increases the antigenic effectiveness of influenzal virus vaccines; peak titres of antibody are significantly higher, and protective levels are maintained for longer periods, than with aqueous vaccine.
Inoculation was offered to all staff at the Springfields (Lancashire) and Dounreay (Caithness) establishments of the Authority. The oil-adjuvant vaccine used incorporated the following strains: A/Sing/l/57/Col, B/Eng/939/59, B/Tai/4/62, and A/Eng/l /61.
Methods
Although the vaccine was offered to all employees, at Springfields only 550 volunteers were forthcoming compared with some 1,800 in a previous trial. It was thought that the reactions which occurred in the previous programme were largely responsible for the relatively small proportion accepting protection. Himmelweit (1963) states that there is only one strong contra-indication to influenza vaccine, namely hypersensitivity to eggs or chicken meat, volunteers who gave a history of allergic reaction to previous injections or had suffered from the major allergic diseases were on this occasion advised against having the vaccine.
Reactions.-An immediate reaction was rare, but within 24 hours a few patients at each establishment complained of cold or influenza-like symptoms. These effects were naturally attributed to the vaccine, but they were apparently not severe enough to be reflected in the certified sickness absence rates. A few days later, a more widespread trend became apparent at both establishments when frequent reports were received of persistent influenza-like symptoms. This feeling of malaise was to persist in many patients for several weeks, and a more recent enquiry has suggested that, in a small proportion of people, the symptom remained for several months.
At Dounreay, a questionnaire was widely distributed some two months after inoculation; 52% of those immunized (590 out of 1,139 persons) returned completed forms. The proportion was slightly lower than this for manual workers, with 42% of those aged 15 to 44 years returning forms, while the proportion for older men was 43 %. Perhaps the higher proportion of returns from non-manual workers (68 %) was not unexpected. This sample returning questionnaires was obviously likely to be biased; probably those without a reaction to the vaccine were less inclined to complete the form than those who experienced side-effects. It is difficult, too, to frame a questionnaire that is both simple and exempt from criticism. The replies on this occasion did however confirm the clinical impressions. Of those returning questionnaires, 47 % reported one or more of the four major reactions.
Even if it be accepted that all who failed to return a form had no reactions (this is an extremely optimistic and unlikely assumption), the percentage with discomfort was higher (24%) than would be considered desirable or acceptable for routine annual inoculation in industry. Some results from the questionnaire (Table 1) have been shown as a proportion of those completing the form and also of all those inoculated. The true values probably lie somewhere between the two ratios. The questions asked were not mutually exclusive. No symptoms, other than those shown, were reported in sufficiently large numbers to be attributable to the vaccine.
Such other conditions mentioned in the questionnaire replies had a normal incidence for this time of year (November).
Selection of Control Groups.-As the number inoculated at Dounreay was about half the establishment strength, it was obviously not possible to obtain a control group there which would be both random and numerically equal to the inoculated group. A control group two-thirds the size of the vaccinated group was therefore proposed, and in order to permit the ready amalgamation of the results from both establishments, a group of similar proportions was selected at Springfields. Since the proportion of female manual workers employed by the Authority is low, the comparison was restricted to male and female non-manual workers and to male manual employees. Female manual workers who volunteered were inoculated, but the results were neither analysed nor included in this report.
The random selection of controls was not carried out by staff from the establishments concerned, thereby obviating any suggestion that a knowledge of the people involved, or their health records, in any way affected the design or control of the trial. From a standard pack of Rand punched cards with a million random digits a control list was made for each establishment, and from these the required control identity numbers were obtained. Details of age, sex, length of service, and other such particulars were then obtained from the two establishments. Most manual workers were engaged on what is loosely termed 'process work', and there were a substantial number of skilled craftsmen and their mates. Salaried non-manual staff were made up of scientific, engineering, supervisory, and administrative employees. Tables 2 and 3 give details of age and staff status. The differences between the two groups were such that they could be expected to have arisen by chance.
Diagnosis and Classification.-The difficulties encountered in the diagnosis of influenza without (Meichen et al., 1962; Norman and Spratling, 1956) .
In this text, the diagnoses given imply classification under the International Statistical Classification (Table 4) . Antibody Production.-Since it was impossible to assess the effectiveness of the vaccine on clinical grounds because of the absence of an epidemic, it was comforting to know that the production of antibodies was satisfactory. Blood samples were taken from 37 of those vaccinated at Springfields and from an equal number of non-vaccinated volunteers who attended for routine medical re-examination. Although these samples were not absolutely random, there was no reason to suppose that they were atypical. Titrations for antibodies to influenza A and B were done on all serum pairs. An antibody During the period under review, normal resignations, retirements, and deaths occurred, and there were two simple courses which could be taken to allow for the effects of this staff wastage. Either those leaving before March 31 could be withdrawn completely from the trial, or, if the proportion was both small and similar in the two groups, then the loss could be ignored. The proportions of staff leaving before March 31 were 2-2 % in the vaccinated group and 3-1 % in the control group at Springfields; the Dounreay figures were respectively 2-2 % and 1-7 %. In fact, the results were very similar by either method (more sophisticated treatment did not seem tSince the control group was numerically two-thirds of the vaccinated group, the actual number of episodes for the control group has been increased by 50% to permit direct comparison. necessary), and Table 8 shows the number of episodes for both establishments by month of onset of absence, and in the various respiratory groupings. The combined rates were 2-2 % for the inoculated group and 2 1 % for the controls. The proportion of staff absent with a diagnosis of influenza was 4 8 % in the inoculated group and 5X1 % in the control group-a difference not significant at the 5 % confidence level.
As the protection afforded in a non-epidemic season is quite clearly below that which most investigators would consider a desirable level, other tabulations suitable for formal significance tests, and rates giving days lost and episodes per 100 at risk, have been omitted; so, too, have tables for the separate establishments, since the pattern was very similar at each.
In the previous Authority investigation, a greater protective effect was found in those aged 45 and over, but in this study the results were similar at each establishment for both age groups.
All certified sickness absence has been included regardless of duration. In fact, in the vaccinated group there were 18 episodes of less than four days' duration. The control group, with a numerical strength two-thirds that of the vaccinated group, had 15 such episodes.
Once sickness had occurred, the length of absence was similar in both groups, and there was no evidence that the vaccine significantly reduced the severity of influenza and other diseases in those who lost time from work. The vaccinated group did show a slightly improved average length of absence in three diagnostic groups (Table 9) .
Discussion
In such a period of limited influenza incidence, The cost of a large immunization programme is quite considerable. In addition to the relatively high cost of the vaccine itself (say 6s. per head, depending on the numbers involved) on average half an hour's working time may be lost per person. The benefits derived from inoculation must therefore be apparent to justify annual routine immunization.
From the volunteer's point of view, acceptability of the vaccine and confidence in its benefits are likely to affect the numbers attending for annual inoculation. Richardson and Kilpatrick (1964) found considerable 'consumer resistance' over a period of three consecutive years, and experience at Springfields tends to confirm their experience. The impression gained at Dounreay, after such a good initial response, is that any future offer of protection would meet with a much smaller number of volunteers.
One reason for this consumer resistance in the Authority is undoubtedly the reactions which have occurred in the two large-scale investigations carried out. In the first, severe reactions within 24 hours of inoculation deterred many volunteers who withdrew before their turn for inoculation came round. In this present series, the persistence of influenza-like feelings for two or more weeks will undoubtedly dissuade many from repeating the experience. This side-effect was prevalent in both manual and nonmanual workers, in both sexes, and throughout all age groupings. It is unlikely to have been psychogenic, nor are these people likely to be restricted to those with low pain thresholds, since if this were so a very high proportion of them might be expected to have complained of pain at the site of injection. From the questionnaire, 23 % of those complaining of this side-effect also reported pain of more than 24 hours' duration at the injection site. Of those completing the questionnaire, but not complaining of persistent malaise, 15 % reported such pain at the injection site. These widespread influenza-like reactions were unlikely to have been caused by the oil-emulsifier since similar reactions have not generally been reported with this emulsion (and an aqueous vaccine of the same strains also produced these effects (Howell and Mackenzie, 1964) ), nor was such a large sample of the population likely to have been hypersensitive. The most probable cause was toxicity of the strains incorporated in the vaccine. This poses a strong challenge to manufacturers. Obviously, the strains in a polyvalent vaccine must be changed to meet anticipated variations in the influenza expected, but since small changes in content may drastically alter the acceptability of the vaccine, intensive testing of this factor must be undertaken before general distribution.
The incidence of pain lasting more than 24 hours at the site of injection was perhaps surprisingly high at an estimated 9 to 18%, but many of those who returned forms also pointed out that the discomfort was slight. It is difficult to estimate the consumer resistance that this sort of reaction provokes.
The value of large-scale annual re-inoculation with polyvalent vaccine still appears to be unproven in a healthy industrial population, although this type of vaccine might prove a good insurance measure in a year when an epidemic was confidently forecast. Its acceptability to healthy volunteers might be improved on such occasions if this aspect were emphasized. The case for further research by the pharmaceutical firms is strong, and so, too, is the need for more controlled trials to evaluate improvements as they arise. The present improved vaccines make even more compelling the inoculation of the high-risk patient.
Since no protective effect could be demonstrated on this occasion, no idea was obtained of the duration of the vaccine's efficacy, but because of the possibility that it could extend for more than 12 months (Medical Research Council Report, 1964) , a further analysis of sickness absence in the two groups will be made if there is any considerable level of influenza next winter.
It is worth noting that although no major allergy reactors were vaccinated, there were no reactions of an allergic nature from minor (e.g., mild asthma) or unknown allergy subjects.
An enquiry of the two major public health laboratories in the vicinity of the establishments involved showed that the vaccine was potentially effective against circulating strains. The north of Scotland laboratory reported that the incidence of infections of the upper respiratory tract attributable to viruses was considerably lower than in recent years, and that there were remarkably few adenovirus referrals.
We are grateful to Dr. T. E. Graham and Dr. F. W. Meichen for their interest in this study and for their permission to examine the medical records of their patients at the Springfields Works of the U.K.A.E.A.
